These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
392 related items for PubMed ID: 25224616
21. Epidemiological impact and cost-effectiveness of providing long-acting pre-exposure prophylaxis to injectable contraceptive users for HIV prevention in South Africa: a modelling study. van Vliet MM, Hendrickson C, Nichols BE, Boucher CA, Peters RP, van de Vijver DA. J Int AIDS Soc; 2019 Dec; 22(12):e25427. PubMed ID: 31855323 [Abstract] [Full Text] [Related]
22. HIV prevention is not all about HIV - using a discrete choice experiment among women to model how the uptake and effectiveness of HIV prevention products may also rely on pregnancy and STI protection. Vickerman P, Quaife M, Kilbourne-Brook M, Mvundura M, Eakle R, Terris-Prestholt F. BMC Infect Dis; 2020 Sep 25; 20(1):704. PubMed ID: 32977745 [Abstract] [Full Text] [Related]
23. "Whatever is in the ARVs, is Also in the PrEP" Challenges Associated With Oral Pre-exposure Prophylaxis Use Among Female Sex Workers in South Africa. Makhakhe NF, Sliep Y, Meyer-Weitz A. Front Public Health; 2022 Sep 25; 10():691729. PubMed ID: 35784260 [Abstract] [Full Text] [Related]
26. Perceptions of HIV Preexposure Prophylaxis Among Young Pregnant Women from Rural KwaZulu-Natal, South Africa. Vazquez L, Moll AP, Kacin A, Ndlovu NE, Shenoi SV. AIDS Patient Care STDS; 2019 May 25; 33(5):214-219. PubMed ID: 31067125 [Abstract] [Full Text] [Related]
27. Family influences on oral PrEP use among adolescent girls and young women in Kenya and South Africa. Ndimande-Khoza MN, Katz AWK, Moretlwe-Delany S, Travill D, Rousseau E, Omollo V, Morton J, Johnson R, Bekker LG, Bukusi EA, Baeten J, Celum C, van der Straten A, Roberts ST. PLoS One; 2023 May 25; 18(11):e0292529. PubMed ID: 37963171 [Abstract] [Full Text] [Related]
32. Preferences for long-acting Pre-Exposure Prophylaxis (PrEP) for HIV prevention among South African youth: results of a discrete choice experiment. Minnis AM, Atujuna M, Browne EN, Ndwayana S, Hartmann M, Sindelo S, Ngcwayi N, Boeri M, Mansfield C, Bekker LG, Montgomery ET. J Int AIDS Soc; 2020 Jun 25; 23(6):e25528. PubMed ID: 32544303 [Abstract] [Full Text] [Related]
35. HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project. Eakle R, Gomez GB, Naicker N, Bothma R, Mbogua J, Cabrera Escobar MA, Saayman E, Moorhouse M, Venter WDF, Rees H, TAPS Demonstration Project Team. PLoS Med; 2017 Nov 25; 14(11):e1002444. PubMed ID: 29161256 [Abstract] [Full Text] [Related]
36. Individual and community-level benefits of PrEP in western Kenya and South Africa: Implications for population prioritization of PrEP provision. Mudimu E, Peebles K, Mukandavire Z, Nightingale E, Sharma M, Medley GF, Klein DJ, Kripke K, Bershteyn A. PLoS One; 2020 Nov 25; 15(12):e0244761. PubMed ID: 33382803 [Abstract] [Full Text] [Related]
38. Influences of geo-spatial location on pre-exposure prophylaxis use in South Africa: positioning microbicides for better product uptake. Govender EM, Mansoor LE, Abdool Karim Q. AIDS Care; 2017 Jun 25; 29(6):734-740. PubMed ID: 27799005 [Abstract] [Full Text] [Related]
40. Implementation strategies for integrating pre-exposure prophylaxis for HIV prevention and family planning services for adolescent girls and young women in Kenya: a qualitative study. Roche SD, Barnabee G, Omollo V, Mogaka F, Odoyo J, Bukusi EA, Morton JF, Johnson R, Celum C, Baeten JM, O'Malley G. BMC Health Serv Res; 2022 Mar 30; 22(1):422. PubMed ID: 35354456 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]